The ESMO Advanced Course on ADC Development, Therapeutic Applications and Research in Gastrointestinal and Gynaecological Cancers 2025: Zurich is a two-day educational event organized by ESMO (European Society for Medical Oncology).

Scheduled for November 28–29, 2025, in Zurich, Switzerland, the course is focused on providing in-depth insights into Antibody-Drug Conjugates (ADCs), including their development, mechanism of action, integration into current clinical guidelines, and management of associated toxicities. The program is accredited with 10 ESMO-MORA category 1 points for Continuing Medical Education.